We first investigated p62/IMP2 expression in a large cohort of HCC patients from the Gene Expression Omnibus (GEO) database (accession numbers GSE 25097, GSE 36376, GSE 14520). This evidence concerns the gene IGF2BP2 and hepatocellular carcinoma.